A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC)

被引：0
|
作者：
Freedman, O. [1 ]
Amir, E. [1 ]
Dranitsaris, G. [1 ]
Dowsett, M. [2 ]
Cole, D. E. C. [3 ]
Hanna, W. [4 ]
O'Malley, F. [5 ]
Folkerd, E. [2 ]
Verma, S. [4 ]
Clemons, M. J. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Royal Marsden Hosp, London SW3 6JJ, England
[3] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada
[4] Odette Canc Ctr, Toronto, ON, Canada
[5] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70919-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：269 / 269
页数：1
相关论文
共 50 条
  • [1] A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer
    Freedman, O. C.
    Amir, E.
    Dranitsaris, G.
    Dowsett, M.
    Cole, D. E. C.
    Kahn, H.
    O'Malley, F.
    Verma, S.
    Clemons, M.
    BREAST CANCER RESEARCH, 2009, 11 : S20 - S20
  • [2] A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer
    OC Freedman
    E Amir
    G Dranitsaris
    M Dowsett
    DEC Cole
    H Kahn
    F O'Malley
    S Verma
    M Clemons
    Breast Cancer Research, 11
  • [3] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    Chin, Y. S.
    Beresford, M. J.
    Ravichandran, D.
    Makris, A.
    BREAST, 2007, 16 (04): : 436 - 439
  • [4] Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 167 - 167
  • [5] A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
    Freedman, O. C.
    Amir, E.
    Hanna, W.
    Kahn, H.
    O'Malley, F.
    Dranitsaris, G.
    Cole, D. E. C.
    Verma, S.
    Folkerd, E.
    Dowsett, M.
    Clemons, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 155 - 161
  • [6] A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer
    O. C. Freedman
    E. Amir
    W. Hanna
    H. Kahn
    F. O’Malley
    G. Dranitsaris
    D. E. C. Cole
    S. Verma
    E. Folkerd
    M. Dowsett
    M. Clemons
    Breast Cancer Research and Treatment, 2010, 119 : 155 - 161
  • [7] Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer
    Bertelli, G
    Garrone, O
    Merlano, M
    Occelli, M
    Bertolotti, L
    Castiglione, F
    Pepi, F
    Fusco, O
    Del Mastro, L
    Leonard, RCF
    ONCOLOGY, 2005, 69 (06) : 471 - 477
  • [8] Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
    Johnston, Stephen R. D.
    Kilburn, Lucy S.
    Ellis, Paul
    Dodwell, David
    Cameron, David
    Hayward, Larry
    Im, Young-Hyuck
    Braybrooke, Jeremy P.
    Brunt, A. Murray
    Cheung, Kwok-Leung
    Jyothirmayi, Rema
    Robinson, Anne
    Wardley, Andrew M.
    Wheatley, Duncan
    Howell, Anthony
    Coombes, Gill
    Sergenson, Nicole
    Sin, Hui-Jung
    Folkerd, Elizabeth
    Dowsett, Mitch
    Bliss, Judith M.
    LANCET ONCOLOGY, 2013, 14 (10): : 989 - 998
  • [9] Exemestane in post-menopausal patients failing treatment with non-steroidal structure aromatase inhibitors: Effects on insulin-like growth factor (IGF) components.
    Martinetti, A
    Bajetta, E
    Celio, L
    Ferrari, L
    Zilembo, N
    Pozzi, P
    Buzzoni, R
    Seregni, E
    Bombardieri, E
    Bichisao, E
    ANNALS OF ONCOLOGY, 2000, 11 : 34 - 35
  • [10] Exemestane-everolimus in HER2-negative, hormonal receptor-positive, post-menopausal metastatic breast cancer with resistance to non-steroidal aromatase inhibitor: a new option
    Gilabert, Marine
    Launay, Simon
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (03) : 325 - 333
12345